• DNase-B Antibody
  • Insulin-Like Growth Factor 2 (IGF-2)
  • The Enhanced Liver Fibrosis (ELF)
  • Actin (Smooth Muscle) Antibody, IgG
  • HIV-1 Integrase Inhibitor Resistance by Sequencing
  • Histamine, Plasma
  • Doxylamine, Urine
  • Amenorrhea
  • Ewing Sarcoma (EWS), 22q12 (EWSR1) Rearrangement, FISH, Tissue
  • Beta-Hydroxybutyrate, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /RET Proto Oncogene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

RET Proto Oncogene Mutation Analysis
Medical Test

Clinical Utility
Access to RET Proto Oncogene Mutation Analysis is restricted.
Loading...